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Abstract
Gallbladder carriage of invasive Salmonella is considered fundamental in sustaining typhoid fever transmission. Bile and
tissue was obtained from 1,377 individuals undergoing cholecystectomy in Kathmandu to investigate the prevalence,
characteristics and relevance of invasive Salmonella in the gallbladder in an endemic area. Twenty percent of bile samples
contained a Gram-negative organism, with Salmonella Typhi and Salmonella Paratyphi A isolated from 24 and 22 individuals,
respectively. Gallbladders that contained Salmonella were more likely to show evidence of acute inflammation with
extensive neutrophil infiltrate than those without Salmonella, corresponding with higher neutrophil and lower lymphocyte
counts in the blood of Salmonella positive individuals. Antimicrobial resistance in the invasive Salmonella isolates was
limited, indicating that gallbladder colonization is unlikely to be driven by antimicrobial resistance. The overall role of
invasive Salmonella carriage in the gallbladder is not understood; here we show that 3.5% of individuals undergoing
cholecystectomy in this setting have a high concentration of antimicrobial sensitive, invasive Salmonella in their bile. We
predict that such individuals will become increasingly important if current transmission mechanisms are disturbed;
prospectively identifying these individuals is, therefore, paramount for rapid local and regional elimination.
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Introduction
Enteric fever is a systemic infection caused by the invasive
bacteria Salmonella Typhi (S. Typhi) and Salmonella Paratyphi A (S.
Paratyphi A). The disease is contracted by the ingestion of fecal
material containing the pathogens [1]. The disease remains
common in regions with poor standards of hygiene and sanitation,
with global estimates suggesting that 27 million people are affected
annually, of which 200,000 people die [2]. With adequate
treatment .95% of patients recover completely from typhoid
[1]. However, an estimated 2–5% of individuals infected with S.
Typhi develop a sustained infection of the gallbladder [3]. These
individuals are referred to as ‘carriers’, and like the infamous
‘typhoid Mary’ [4], are outwardly asymptomatic, continue to
intermittently shed organisms for a prolonged period and often
have no recollection of an acute episodes of typhoid [1].
During acute typhoid, invasive Salmonella cross the intestinal
epithelial barrier, invade and survive within macrophages,
eventually reaching the bone marrow, liver, pancreas and spleen
[5]. Invasion of the gallbladder occurs either directly from the
blood or by retrograde spread from the bile [1]. In a subset of
individuals infected with S. Typhi, the organisms chronically
colonize the gallbladder and carriers shed these organisms
intermittently into the intestinal lumen and thus in the feces. It
is gallbladder colonization and fecal shedding that form a central
dogma for the transmission and persistence of typhoid fever. As
a consequence of the internal localization of organisms, this dogma
is difficult to challenge in humans and the host-restricted nature of
the relevant pathogens make carriage difficult to replicate precisely
in non-mutant mouse models [6]. As a result, data regarding the
prevalence, bacteriology and mechanisms of carriage are sparse.
The only population-based study estimating chronic Salmonella
carriage in an endemic setting is from Chile where investigators
gathered data from autopsies, calculating a carriage rate of
694 per 100,000 [3].
Investigations of Salmonella carriage suggest that the propensity
to become a chronic carrier follow the typical epidemiology of
gallbladder disease. Thus, the likelihood of carriage increases with
age and is more common in females [7]. Existing data also imply
that individuals with gallstones or other gallbladder abnormalities
are at increased risk of carriage [8]. These epidemiological theories
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are supported by laboratory-based investigations, which have
shown that Salmonella can form biofilms and survive for prolonged
period on gallstones [9,10].
There remains a significant burden of typhoid fever across Asia,
yet the understanding of Salmonella carriage in these populations is
limited. We have found previously that S. Paratyphi A can be
isolated from the gallbladders of patients undergoing cholecystec-
tomy and we suggested that carriage of invasive Salmonella play
a pivotal role in the persistence of these pathogens in Kathmandu,
Nepal [11]. We aimed to define the microbiology and epidemi-
ology of invasive Salmonella carriage in Kathmandu. We demon-
strate that S. Typhi and S. Paratyphi A are present in the
gallbladder in a high concentration, are less common than other
Gram-negative organisms, are not associated with lymphocytic
infiltration in the gallbladder tissue, and do not exhibit resistance
to multiple antimicrobials.
Results
Microbiological Examination of Bile from
Cholecystectomy Patients
From June 2007 until October 2010, a total of 1,496 patients
underwent cholecystectomy for acute or chronic cholecystitis at
Patan hospital in Kathmandu. From the 1,496 patients, bile
samples from 1,377 individuals were obtained and subjected to
microbiological examination; 119 (8%) patients either denied
consent or were unavailable for recruitment. A Gram-negative
organism was isolated from 20% (274/1,377) of the bile samples.
E. coli, Salmonella spp. and Klebsiella spp. were the most commonly
isolated organisms, found in 78 (5.7%), 48 (3.5%) and 41 (3.0%) of
the bile samples, respectively (Table 1). The remainder of the
culture positive bile samples contained a range of organisms
including Psuedomonas spp., Acinetobacter spp., Enterobacter spp.,
Citrobacter freundii, Vibrio spp. and Serratia marcescens (Table 1). Of
the 48 Salmonellae isolated, 24 (1.7%) were S. Typhi, 22 (1.6%) were
S. Paratyphi A and two (0.1%) were S. enterica group C.
Forty-six Salmonella isolates were available for antimicrobial
susceptibility testing by disc diffusion. Fifty-nine percent (27/46) of
the Salmonella isolates were resistant to nalidixic acid, and a single
S. Paratyphi A isolate was resistant to both nalidixic acid and
ciprofloxacin. All S. Typhi and S. Paratyphi A strains were
susceptible to ceftriaxone, chloramphenicol, gatifloxacin and
ofloxacin and we identified no multi-drug resistant (MDR)
(resistant to chloramphenicol, ampicillin and co-trimoxazole)
isolates. One S. enterica group C isolate demonstrated resistance
to nalidixic acid, ceftriaxone, gatifloxacin and chloramphenicol
(Table 1).
Baseline data, stratified by microbiological culture result are
shown in Table 2. Notably, fitting with the typical epidemiological
characteristics of cholelithiasis, 77% (1,066/1,377) of the patients
were female and the median age was 39 years (range: 16 to 76
years). The median age of those with Salmonella in their bile was 35
years (range: 18 to 67 years) and 73% were female. It is
noteworthy that none of the pre-surgical stool cultures from any
patients were Salmonella positive and, when questioned, only 15%
(7/48) of the Salmonella bile-positive patients had a memorable
history of typhoid, none of which had been confirmed by
microbiological culture. From available records, 16% (7/43) of
Salmonella bile-positive patients reported .5 days of fever on entry,
7% (3/46) were admitted with jaundice, 5% (2/41) had a palpable
gallbladder and 4% (2/45) were admitted with pancreatitis.
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Bacterial Load of Salmonella in Bile
To quantify the bacterial load in the bile, real-time PCR was
performed on total nucleic extracted from the bile of six S.
Paratyphi A positive individuals and 12 S. Typhi positive
individuals. All qualitative serovar specific PCR data corresponded
precisely with the culture data. The median target copy numbers/
bacterial loads were 9.36104 (IQR 56104–2.36105) CFU/ml21
for S. Paratyphi A and 5.26104 (IQR 26104–7.286105) CFU/
ml21 for S. Typhi. The difference in bacterial load between the
two organisms was non-significant (p = 0.93; Mann-Whitney U
test), yet, were approximately two and three orders of magnitude
greater than those previously reported in bone marrow and blood,
respectively [12,13].
Hematological and Biochemical Characteristics
The 1,377 individuals undergoing cholecystectomy were di-
vided into three groups on the basis of their bile culture results:
Salmonella positive, culture negative, and culture positive for non-
Salmonella. Individuals that were Salmonella positive were more
likely to have experienced continuous right upper-quadrant pain
(10%, 5/48) compared to those that were culture negative (3%,
37/1,151) (p = 0.008, chi squared test) and those that were culture
positive for non-Salmonella (2%, 5/214) (p = 0.008, chi squared test).
Hematology and biochemistry data from the patients were
compared using the Mann-Whitney U test (Table 3). There was
no significant difference in liver enzyme or bilirubin levels between
the Salmonella positive group and the other two groups. Yet, the
Salmonella positive group had a higher median neutrophil count
and a lower median lymphocyte count than the culture negative
group and the culture positive non-Salmonella group (Table 3).
Surgical and Histopathological Characteristics
The major surgical and post-surgical characteristics of the
gallbladders from the three groups were compared using Fisher’s
exact test (Table 4). The majority of Salmonella positive individuals
had gallstones (96%, 46/48); yet, there was no significant
difference in the proportion of individuals with gallstones between
the three groups. We did, however, identify several gallbladder
characteristics that were associated the presence of Salmonella.
Namely, gallbladder distension and inflammation was more
frequently observed in the Salmonella positive group than the
culture negative group and the non-Salmonella culture positive
group (Table 3). Furthermore, the presence of an empyema (pus
within the gallbladder cavity) was also more common in the
Salmonella positive group than the other two groups. Inflammation
was more likely to be due to polymorphonuclear infiltration than
lymphocytic infiltration in the Salmonella infected gallbladder tissue,
with 13% (6/48) of the Salmonella positive gallbladder specimens
having massive neutrophil infiltrate near the lumen, compared to
4% (51/1,151) and 5% (10/214) of the culture negatives and the
non-Salmonella culture positives, respectively. Furthermore, an
additional 15% (7/48) of the Salmonella positive gallbladder
specimens had acute-on-chronic cholecystitis (neutrophil infiltrate
near the lumen with lymphocyte infiltrate and dysplasia in the
mucosa) compared to 5% (10/214) and 7% (14/214) of the culture
negatives and the non-Salmonella culture positives, respectively
(Table 3.). Correspondingly, chronic inflammation without large
neutrophil infiltrate was not observed in gallbladder tissue from
the Salmonella positive group.
Discussion
The mechanism of gallbladder infection/colonization remains
contentious, and it is unknown if Salmonella promote gallbladder
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damage during chronic infection or if the organisms exploit
existing gallbladder damage to stimulate colonization [14]. Bile is
typically sterile, and consists of organic and inorganic compounds,
bile acids, cholesterol, phospholipids and the pigment biliverdin.
Sterility is partially maintained by the secretion of IgA and mucus,
preventing bacterial survival and adhesion to the surface of the
lumen and the major bile duct, respectively [15]. Here, we found
a wide array of organisms in the bile of individuals undergoing
cholecystectomy, some of which have been previously isolated
from the gallbladder [16–18]. Again, whether these organisms
Table 3. The haematological and the biochemical characteristics of the Salmonella positive, culture negative and the culture
positive for non-Salmonella bile culture groups.
Hematology Culture negative Culture positive non-Salmonella Salmonella positive p1* p2*
n median IQR n median IQR n median IQR
Total cell (6103/mL) 953 7.9 6.6–9.5 188 7.85 6.45–10.15 42 9.45 6.4–14 0.025 0.058
Neutrophil (6103/mL) 917 66 58–74 177 65 58–75 41 72 60–82 0.012 0.042
Lymphocyte (6103/mL) 914 31 24–38 175 31 23–38 40 24.5 17–36 0.007 0.040
Monocyte (6103/mL) 270 1 1–2 70 1.5 1–2 9 1 1–2 0.676 0.848
Eosinophil (6103/mL) 641 2 1–4 131 2 1–4 22 2 2–4 0.999 0.515
Basophil (6103/mL) 54 0 0–1 14 0 0–0 1 6 – 0.058 0.020
Total bilirubin (mg/mL) 965 0.8 0.68–1 190 0.8 0.7–1 42 0.86 0.7–1.1 0.119 0.280
Conjugated bilirubin (mg/mL) 950 0.2 0.19–0.26 186 0.2 0.18–0.24 41 0.2 0.2–0.28 0.414 0.419
AST (u/L) 961 30 23–41 190 29.5 23–40 42 28 24–38.9 0.878 0.986
ALT (u/L) 960 30 21.9–43 188 29.5 21–43.5 42 30.5 24–41 0.898 0.953
ALP (u/L) 941 122 82–209 188 150.5 94.5–232.5 42 124.5 96–191 0.622 0.276
Amylase (u/L) 136 61.5 41.5–252.5 20 57.5 38–86.5 9 87 34–190 0.867 0.437
*Mann-Whitney U test, boldface indicates p#0.05.
p1: Comparing culture-negative to Salmonella-positive patients.
p2: Comparing culture positive for non-Salmonella to Salmonella-positive patients.
IQR: Interquartile range.
doi:10.1371/journal.pone.0047342.t003
Table 4. The gallbladder characteristics within the Salmonella positive, culture negative and the culture positive for non-
Salmonella bile culture groups.
Characteristic Culture negative Culture positive non-Salmonella Salmonella positive p1* p2*
n=1,103 n=214 n=48
Gallbladder tissue thickness
Thick (.4 mm) 173 (15.7) 36 (16.8) 10 (20.8) 0.350 0.602
Normal (4 mm) 493 (44.7) 86 (40.0) 21 (43.8)
Thin (,4 mm) 74 (6.7) 12 (5.6) 1 (2.1)
Gallbladder size
Contracted 108 (9.8) 25 (11.7) 1 (2.1) 0.026 0.035
Distended 221 (20.0) 52 (24.3) 15 (31.3)
Gall stones
None 19 (1.7) 6 (2.8) 3 (6.3) 0.101 0.481
Single 344 (31.2) 62 (29.0) 14 (29.2)
Multiple 684 (62.0) 133 (62.1) 28 (58.3)
Pathology
Inflammation 93 (8.4) 17 (7.9) 8 (16.7) 0.046 0.060
Empyema 90 (8.2) 21 (9.8) 10 (20.8) 0.003 0.033
Sludge 57 (5.2) 8 (3.7) 1 (2.1) 0.338 0.581
Mucocele 50 (4.5) 7 (3.3) 1 (2.1) 0.427 0.664
*Fisher’s exact test, boldface indicates p#0.05.
p1: Comparing culture-negative to Salmonella-positive patients.
p2: Comparing culture-positive, Salmonella-negative to Salmonella-positive patients.
doi:10.1371/journal.pone.0047342.t004
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functionally stimulate cholecystitis or cholelithiasis, or merely have
the ability to colonize damaged gallbladders, remains unclear. Our
data confirm that non-Salmonellae organisms, with a spectrum of
pathogenic potential, are as equally adept at colonizing the
gallbladder and surviving within the bile as typhoidal Salmonella.
Yet, non-Salmonellae appear not to stimulate the same pathology as
Salmonella; Salmonella infected tissue was more commonly associated
with systemic and local acute inflammatory responses. Mouse
experiments, utilizing Salmonella Typhimurium, have shown that
Salmonella can replicate within the epithelial cells of the gallbladder
[19], and that colonized gallbladders displayed evidence of the
epithelial destruction and local neutrophil infiltrate. Here, we also
find extensive neutrophil infiltrate, yet are unable to confirm if the
bacteria are damaging the tissue or colonizing previously damaged
tissue. However, as shown by an increased prevalence of
gallbladder distention, right upper quadrant pain, empyema and
a raised systemic neutrophil count, there is an evident association
of invasive Salmonella in the gallbladder with an acute inflamma-
tory response.
We have previously noted the presence of individuals in
Kathmandu with Salmonella in their gallbladder, highlighting the
presence of S. Paratyphi A [11]. The role of chronic carriage of S.
Paratyphi A has received much less attention than that of S. Typhi
and it is unknown as to what extent chronic gallbladder carriage is
contributing to the increasing burden of S. Paratyphi A across
many parts of Asia [20]. Enteric fever caused by S. Paratyphi A
increased from 17.5% (155/885) in 1993 to 34% (926/2,718) in
2003 in the location of this study [21].
Furthermore, we found an almost equal ratio of S. Typhi and
S. Paratyphi A (1:0.9) isolated from bile, yet the isolates from blood
from acutely infected patients over the same period is lower (1:0.4)
[22]. This disparity may result from a multitude of factors, but
may predict that S. Paratyphi A is more adept at inducing carriage
in this population, or, once in the gallbladder, may be more likely
to induce an acute inflammatory response, requiring a surgical
intervention, than S. Typhi.
We found that 3.5% of the individuals undergoing gallbladder
surgery had invasive Salmonella in their bile in this area with a high
incidence of enteric fever [23]. A report from a similar patient
demographic in India suggest an equivalent rate of ,5%, and in
Chile, 7.3% of bile cultures were found to be positive for Salmonella
[7]. The long-term carriage of invasive Salmonella in the gallbladder
is thought to be central to the maintenance and transmission of
these human-restricted pathogens [14]. However, data from our
previous work in Kathmandu suggests that direct transmission
plays a negligible role in acute infections, and we have
hypothesized that carriers merely act as a reservoir for maintaining
local strain diversity in areas of high endemicity [22]. Here, we
found antimicrobial resistance to only nalidixic acid in the
Salmonella from the gallbladder. Although nalidixic acid resistance
often precedes resistance to other fluoroquinolones, these isolates
were susceptible to gatifloxacin and ofloxacin. Firstly, these data
show that infection with an antimicrobial resistant organism is not
likely to be associated with Salmonella carriage. Secondly, if one
considers nalidixic acid resistance as a proxy marker of contem-
porary strains, the organisms in the gallbladder have probably
been there for some time (i.e. from a period when nalidixic acid
resistance was less prevalent) [21,24]. Nalidixic acid resistance is
a growing problem in Kathmandu. From an ongoing clinical trial
enrolling enteric fever patients over the last two years at Patan
Hospital, 80% (171/214) of invasive Salmonella isolates demon-
strated resistance to nalidixic acid, which is greater than the
proportion (59%) found from bile isolates in the current study
(unpublished data). This evidence supports our current hypothesis
of gallbladder carriage playing a limited role in the acute
transmission of typhoid in Kathmandu.
Whilst we argue that in locations such as Kathmandu, the role
of carriers in typhoid fever transmission may be negligible, it is
reasonable to suggest that those shedding invasive Salmonella play
a vital important role in low transmission setting. In the USA, up
to 30% of typhoid fever infections are anticipated to result from
contact with a chronic carrier [25]. Therefore, these individuals
will become increasingly important as indirect transmission this
area begins to subside after the introduction of an effective
intervention strategy. However, currently there is no appropriate
diagnostic test for the detection of long-term carriers [26]. Bile
cultures from string devices are considered effective [27], but are
impractical for screening large cohorts [28]. The presence of
gallbladder disease is, perhaps, currently the best clinical predictor
of carriage of invasive Salmonella [7]. However, it remains unclear
as to why some patients progress to become chronic shedders and
others do not. The development of a rapid diagnostic for the
detection of invasive Salmonella carriage should accelerate regional
elimination of typhoid and add insight into the epidemiological
role of these individuals.
One of the major caveats of our study that limits the
generalizability of our findings is the fact that our passively
acquired patient population may not accurately reflect the general
population of Kathmandu. Additionally, all patients in the study
had some form of gallbladder abnormality, although it is unclear
whether such abnormalities had been induced by the infecting
organisms. Nevertheless, in the absence of an alternative
methodology, our study represents a reasonable estimation of
the burden and mechanism of invasive Salmonella carriage.
In conclusion, we have calculated a prevalence of 3.5% of
invasive Salmonella in bile from patients undergoing cholecystec-
tomy in Kathmandu, Nepal. We demonstrate that S. Paratyphi A
is almost as prevalent as S. Typhi in the gallbladder in this
population and that carriage is not driven by antimicrobial
resistance. The overall role of invasive Salmonella carriage in
settings such as Kathmandu is not understood, and we suggest that
organisms in the gallbladder may not play a dominant role in
acute typhoid fever in this location. We predict, however, that
carriers will become more important if current transmission
mechanisms are disturbed; prospectively identifying these individ-
uals is paramount for rapid local and regional elimination.
Methods
Ethics Statement
This study was conducted according to the principles expressed
in the Declaration of Helsinki and was approved by the
institutional ethical review boards of Patan Hospital, The Nepal
Health Research Council and The Oxford University Tropical
Research Ethics Committee (OXTREC, Reference number:
2108). All enrollees were required to provide written informed
consent for the collection and storage of all samples and
subsequent data analysis. In the case of those under 18 years of
age, a parent or guardian was asked to provide written informed
consent.
Setting and Study Population
The study was conducted at Patan Hospital, a 318-bed
government hospital located in the Lalitpur Sub-Metropolitan
City in the Kathmandu valley, Nepal. Patan Hospital provides
both emergency and elective inpatient services. Typhoid fever is
a common complaint at Patan Hospital and S. Typhi and
S. Paratyphi A are the most common bacteria cultured from blood
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of febrile patients in this location. Antimicrobials are available
without prescription in the community in a variety of public and
private outlets and there are numerous private physician clinics
where patients may seek advice and clinical diagnosis for febrile
disease. There has been no widespread implementation of
a typhoid vaccine in this area, yet a generic typhoid Vi vaccine
is available for purchase in some health care settings. However, at
the time of this investigation there was limited community uptake
of the vaccine.
The surgical department performs approximately 400 chole-
cystectomies annually. For the purposes of this study, consecutive
patients admitted to the surgical ward from June 2007 to October
2010 for either open cholecystectomy or laparotomy surgery for
symptomatic cholelithiasis between 8 am and 4 pm were ap-
proached for participation. All patients who gave written informed
consent were eligible for the study; there were no exclusion
criteria. All enrollees were also required to provide written
informed consent for the collection, use and storage of the tissue
removed during surgery samples. A questionnaire related to the
patient’s health and demographics was administered prior to
surgery along with a stool sample for microbiological culture.
Surgeons collected bile samples and gallbladder tissue during the
procedure.
Gallbladder Morphology and Histopathology
Patients were routinely examined by ultrasonography before
surgery to assess the presence of gallstones and to detect
inflammation. The surgeon performing the procedure curated
a report, assessing the thickness of the gallbladder wall (stratified
into three categories, thick: .4 mm, normal: 4 mm and thin:
,4 mm), the presence and the number of gallstones, the presence
and characteristics of fluid (pus: empyema, mucoid/clear/watery:
mucocele and sludge) and overall morphology (contracted or
distended). Hematocrit, total leukocytes with differential count,
total bilirubin, conjugated bilirubin, alanine aminotransferase
(ALT), aspartate aminotransferase (AST), and amylase were
measured prior to surgical intervention. All extracted tissue was
subjected to a histopathological examination to assess/confirm the
extent of the inflammation; all histopathology was performed by
the same skilled technician who was blinded to presence or
absence of bacteria within the bile. All sections we examined by
light microscopy after staining with heamatoxylin and eosin.
Inflammation was identified by tissue morphology and the
presence of neutrophils (acute) and lymphocytes (chronic).
Microbiological Culture, Antimicrobial Susceptibility
Testing and Real-time PCR
Bile and stool were collected for culture from all patients
undergoing cholecystectomy. Bile was inoculated into equal
volumes of Selenite F broth and Peptone broth and incubated at
37uC overnight. Broths were sub-cultured onto MacConkey agar
and Xylene Lysine Deoxycholate (XLD) agar. After overnight
incubation at 37uC the plates were examined for the growth of
Gram-negative bacteria and colonies were identified by standard
microbiological methods and identified by API20E manufactured
by bioMerieux, Inc. S. Typhi and S. Paratyphi A isolates were
confirmed by slide agglutination by specific antisera (Murex
Biotech, Biotech, England). The antimicrobial sensitivity profile
was performed by Kirby Bauer disc diffusion method using
standard BSAC and CLSI guidelines [29]. The antimicrobials
tested were amoxicillin, chloramphenicol, co-trimoxazole, nali-
dixic acid, ciprofloxacin, ofloxacin, ceftriaxone and gatifloxacin.
The minimum inhibitory concentrations (MICs) were performed
for nalidixic acid, ciprofloxacin, ofloxacin and azithromycin by E-
test (AB Biodisk, Sweden). Susceptibility to ciprofloxacin and
ofloxacin were evaluated using newly suggested susceptibly
breakpoints for these antimicrobials; $0.125 mg/ml and
$0.25 mg/ml for ciprofloxacin and ofloxacin respectively [30].
Real-time PCR was performed using a standard curve for
quantitation as previously described [12], using DNA extracted
from 200ml bile samples as template.
Data Analysis
Data were entered into a database using Excel 2007 (Microsoft)
and analyzed using Stata/IC version 9.2 (StataCorp, TX, USA).
Chi-square and Fisher’s exact tests were used to compare
proportions between groups and Mann-Whitney U tests were
used for continuous non-parametric data. P-values #0.05 were
considered to be statistically significant.
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